WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT） / Chinese Thoracic Oncology Group（C-TONG）. Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
|
Citation:
|
WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT） / Chinese Thoracic Oncology Group（C-TONG）. Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
|
WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT） / Chinese Thoracic Oncology Group（C-TONG）. Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
|
Citation:
|
WU Yi-long, LU Shun, ZHOU Qing-hua, ZHANG Li, CHENG Ying, WANG Jie, WANG Bu-hai, HU Cheng-ping, LIN Li-zhu, ZHONG Wen-zhao, SONG Yong, YANG Nong, DONG Xiao-rong, ZHAO Jian, YANG Hai-hong, GUO Hui, YAN Xiao-long, LIU Hong-xu, MA Rui, LIN Jie, LIU Si-yang, CHEN Chun, WANG Li-feng, ZHOU Cheng-zhi, ZHOU Ming, WU Fang, YANG Xue-ning, DU Ying-ying, YAO Yu, SHAO Yang, HONG Shao-dong, CUI Jiu-wei, QUAN Xue-ping, CHEN Rong-rong, WU Jia-yan, ZHANG Jia-tao, ZHOU Jian-ya, WANG Bin-chao, CHENG Chao, WANG Hui-juan, LIU Jing-jing, WU Lin, HUANG Yan, KUANG Yu-kun, ZHANG Yong-chang, HU Jie, YANG Jin-ji, FENG Wei-neng, SU Wen-mei, FAN Yun, YANG Fan, CHEN Ming, TANG Ke-jing, PAN Yi, SHEN Peng, LIU An-wen, ZHANG Hai-bo, LIANG Wen-hua, ZHOU Qing, MA Zhi-yong, CAI Xiu-yu, LIU Hui, CHEN Long-fei, CHUAI Shao-kun, SHAN Jian-zhen, ZHENG Yan-fang, YOU Chang-xuan, ZHU Xiao-xia, LI Li, ZHANG Tong-mei, TU Hai-yan, LIN Wu-rong, ZHANG Xu-chao, ZHOU Peng-hui, KE Zun-fu, LIANG Hui-ying, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT） / Chinese Thoracic Oncology Group（C-TONG）. Management of Stage Ⅲ Non-Small Cell Lung Cancer: Consensus and Contention[J]. Journal of Evidence-Based Medicine, 2022, 22(3): 129-136. DOI: 10.12019/j.issn.1671-5144.2022.03.001
|
DownLoad: